Gene · 5883
Papers1,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,553
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxidative Stress and Deregulated DNA Damage Response Network in Lung Cancer Patients. | Biomedicines | 2022 | 35740268 | PubTator, text mining | PubMed |
| Fun30 and Rtt109 Mediate Epigenetic Regulation of the DNA Damage Response Pathway in C. albicans. | J Fungi (Basel) | 2022 | 35736042 | PubTator, text mining | PubMed |
| Structural basis for molecular interactions on the eukaryotic DNA sliding clamps PCNA and RAD9-RAD1-HUS1. | J Biochem | 2022 | 35731009 | PubTator, text mining | PubMed |
| Hallmarks of DNA replication stress. | Mol Cell | 2022 | 35714587 | PubTator, text mining | PubMed |
| A field guide to the proteomics of post-translational modifications in DNA repair. | Proteomics | 2022 | 35695711 | PubTator, text mining | PubMed |
| A ferrocene-containing nucleoside analogue targets DNA replication in pancreatic cancer cells. | Metallomics | 2022 | 35689667 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Structural Details of BH3 Motifs and BH3-Mediated Interactions: an Updated Perspective. | Front Mol Biosci | 2022 | 35685242 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer. | Biomedicines | 2022 | 35625741 | PubTator, text mining | PubMed |
| The Potential Important Role of Mitochondrial Rieske Iron-Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease. | Biomedicines | 2022 | 35625694 | PubTator, text mining | PubMed |
| Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints. | Antioxidants (Basel) | 2022 | 35624810 | PubTator, text mining | PubMed |
| Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance. | Cancer Drug Resist | 2022 | 35582542 | PubTator, text mining | PubMed |
| CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status. | Int J Mol Sci | 2022 | 35563313 | PubTator, text mining | PubMed |
| Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis. | EBioMedicine | 2022 | 35561450 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| Delineation of a minimal topoisomerase II binding protein 1 for regulated activation of ATR at DNA double-strand breaks. | J Biol Chem | 2022 | 35490781 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair. | Front Oncol | 2022 | 35463312 | PubTator, text mining | PubMed |
| Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR). | Molecules | 2022 | 35458687 | PubTator, text mining | PubMed |
| HUS1 as a Potential Therapeutic Target in Urothelial Cancer. | J Clin Med | 2022 | 35456300 | PubTator, text mining | PubMed |
| Epigenetic modification regulates tumor progression and metastasis through EMT (Review). | Int J Oncol | 2022 | 35445731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5883/papers?page=12